Kallikrein 6 (KLK6) levels have been shown to be elevated in patients with multiple types of malignancies, including glioblastoma,77 colorectal,78 laryngeal,79 gastric,80 and ovarian cancers,81 as well as prostate cancer. Here, KLK6 is linked to prostate carcinoma.